These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma. Choi JW, Kim Y, Lee JH, Kim YS. Hum Pathol; 2013 Jul; 44(7):1375-81. PubMed ID: 23380077 [Abstract] [Full Text] [Related]
4. Clinicopathological features of 49 primary gastrointestinal diffuse large B-cell lymphoma cases; comparison with location, cell-of-origin, and frequency of MYD88 L265P. Nagakita K, Takata K, Taniguchi K, Miyata-Takata T, Sato Y, Tari A, Ohnishi N, Noujima-Harada M, Omote S, Nakamura N, Iwamuro M, Maeda Y, Okada H, Tanimoto M, Yoshino T. Pathol Int; 2016 Aug; 66(8):444-52. PubMed ID: 27439595 [Abstract] [Full Text] [Related]
6. Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis. Lee JH, Jeong H, Choi JW, Oh H, Kim YS. Sci Rep; 2017 May 11; 7(1):1785. PubMed ID: 28496180 [Abstract] [Full Text] [Related]
7. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type. Pham-Ledard A, Beylot-Barry M, Barbe C, Leduc M, Petrella T, Vergier B, Martinez F, Cappellen D, Merlio JP, Grange F. JAMA Dermatol; 2014 Nov 11; 150(11):1173-9. PubMed ID: 25055137 [Abstract] [Full Text] [Related]
9. Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation. Wang CZ, Lin J, Qian J, Shao R, Xue D, Qian W, Xiao GF, Deng ZQ, Yang J, Li Y, Chen XX. Clin Biochem; 2013 Mar 11; 46(4-5):385-7. PubMed ID: 23178471 [Abstract] [Full Text] [Related]
11. MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome. Rovira J, Karube K, Valera A, Colomer D, Enjuanes A, Colomo L, Martínez-Trillos A, Giné E, Dlouhy I, Magnano L, Delgado J, Martínez A, Villamor N, Campo E, López-Guillermo A. Clin Cancer Res; 2016 Jun 01; 22(11):2755-64. PubMed ID: 26792260 [Abstract] [Full Text] [Related]
13. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma. Aggarwal V, Das A, Bal A, Srinivasan R, Das R, Prakash G, Malhotra P, Varma S. Appl Immunohistochem Mol Morphol; 2019 Apr 01; 27(4):311-318. PubMed ID: 29734251 [Abstract] [Full Text] [Related]
14. High prevalence of the MYD88 mutation in testicular lymphoma: Immunohistochemical and genetic analyses. Oishi N, Kondo T, Nakazawa T, Mochizuki K, Tanioka F, Oyama T, Yamamoto T, Iizuka J, Tanabe K, Shibata N, Kirito K, Katoh R. Pathol Int; 2015 Oct 01; 65(10):528-35. PubMed ID: 26388135 [Abstract] [Full Text] [Related]
16. CD79B and MYD88 mutations in diffuse large B-cell lymphoma. Kim Y, Ju H, Kim DH, Yoo HY, Kim SJ, Kim WS, Ko YH. Hum Pathol; 2014 Mar 01; 45(3):556-64. PubMed ID: 24444466 [Abstract] [Full Text] [Related]